Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms

NCT01523132 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.

NCT NCT01523132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01523132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Persistent Pain After Breast Cancer Treatment (PPBCT) - Risk Factors and Pathophysiological Mechanisms
Lead sponsor
Rigshospitalet, Denmark
Phase
Observational
Overall status
Completed
Start date
November 30, 2011
Completion date
November 30, 2014
Enrollment
545 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, lymphedema, neuropathic pain, neuropathy, persistent pain